Lisa F P Ng Selected Research

Chikungunya Fever

1/2019	Chikungunya virus drug discovery: still a long way to go?
1/2018	Paradoxical Effect of Chloroquine Treatment in Enhancing Chikungunya Virus Infection.
6/2013	An essential role of antibodies in the control of Chikungunya virus infection.
12/2012	Longitudinal analysis of the human antibody response to Chikungunya virus infection: implications for serodiagnosis and vaccine development.
1/2011	Persistent arthralgia induced by Chikungunya virus infection is associated with interleukin-6 and granulocyte macrophage colony-stimulating factor.
1/2009	IL-1beta, IL-6, and RANTES as biomarkers of Chikungunya severity.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Lisa F P Ng Research Topics

Disease

32	Infections 06/2022 - 01/2009
17	COVID-19 06/2022 - 01/2020
8	Inflammation (Inflammations) 06/2021 - 11/2011
6	Zika Virus Infection 10/2021 - 01/2017
6	Chikungunya Fever 01/2019 - 01/2009
6	Arthralgia (Joint Pain) 01/2018 - 01/2011
5	Alphavirus Infections 04/2021 - 10/2013
4	Viremia 01/2018 - 01/2011
4	Virus Diseases (Viral Diseases) 01/2018 - 01/2015
2	Ebola Hemorrhagic Fever 11/2021 - 07/2017
2	Disease Progression 01/2021 - 01/2018
2	Hypoxia (Hypoxemia) 09/2020 - 01/2020
2	Necrosis 10/2017 - 01/2017
2	Myositis (Idiopathic Inflammatory Myopathies) 10/2017 - 10/2013
2	Congenital Abnormalities (Deformity) 01/2017 - 01/2017
1	Pneumonia (Pneumonitis) 01/2022
1	Viral Pneumonia 11/2021
1	Respiratory Insufficiency (Respiratory Failure) 01/2021
1	Post-Acute COVID-19 Syndrome 01/2021
1	Convalescence 01/2021
1	Hypertension (High Blood Pressure) 01/2021
1	Kidney Diseases (Kidney Disease) 01/2021
1	Critical Illness (Critically Ill) 01/2021
1	Fever (Fevers) 09/2020
1	Malaria 01/2020
1	Coinfection 01/2020
1	Arbovirus Infections 01/2019
1	Cerebral Malaria 01/2018
1	Non-alcoholic Fatty Liver Disease 01/2018
1	Liver Diseases (Liver Disease) 01/2018
1	Lymphopenia (Lymphocytopenia) 01/2018
1	Metabolic Diseases (Metabolic Disease) 01/2018
1	Musculoskeletal Diseases (Musculoskeletal Disease) 10/2017
1	Neoplasms (Cancer) 03/2017
1	Edema (Dropsy) 01/2017

Drug/Important Bio-Agent (IBA)

12	CytokinesIBA 06/2021 - 01/2009
11	VaccinesIBA 06/2022 - 12/2011
11	Antiviral Agents (Antivirals)IBA 01/2019 - 05/2010
10	AntibodiesIBA 01/2021 - 04/2012
7	Proteins (Proteins, Gene)FDA Link 01/2021 - 12/2012
5	Immunoglobulin G (IgG)IBA 11/2021 - 04/2012
5	EpitopesIBA 01/2021 - 04/2012
5	InterferonsIBA 01/2018 - 06/2015
4	Immunoglobulin M (IgM)IBA 11/2021 - 12/2011
4	Hepatocyte Growth Factor (Growth Factor, Hepatocyte)IBA 01/2021 - 01/2011
4	Interleukin-6 (Interleukin 6)IBA 01/2018 - 01/2011
3	Peptides (Polypeptides)IBA 08/2020 - 04/2012
2	COVID-19 VaccinesIBA 06/2022 - 01/2021
2	Oxygen (Dioxygen)IBA 11/2021 - 01/2020
2	Biomarkers (Surrogate Marker)IBA 11/2021 - 01/2009
2	LigandsIBA 10/2021 - 10/2017
2	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 06/2021 - 01/2021
2	InterleukinsIBA 06/2021 - 04/2017
2	SARS-CoV-2 spike proteinIBA 01/2021 - 01/2020
2	Immunoglobulin A (IgA)IBA 01/2021 - 01/2021
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2021 - 01/2009
2	Indicators and Reagents (Reagents)IBA 01/2020 - 06/2015
2	Neutralizing AntibodiesIBA 01/2020 - 01/2018
2	Pharmaceutical PreparationsIBA 01/2019 - 11/2016
2	RNA (Ribonucleic Acid)IBA 03/2018 - 07/2017
2	Messenger RNA (mRNA)IBA 03/2018 - 10/2017
2	ChemokinesIBA 10/2017 - 01/2009
2	Interleukin-18 (Interleukin 18)IBA 10/2017 - 01/2017
2	PyrrolesIBA 01/2017 - 12/2015
2	Interleukin-2 (IL2)IBA 11/2016 - 06/2015
1	Interferon Type IIBA 01/2022
1	Macrophage Inflammatory Proteins (Macrophage Inflammatory Protein 1)IBA 06/2021
1	Stem Cell FactorIBA 06/2021
1	Brain-Derived Neurotrophic Factor (BDNF)IBA 06/2021
1	remdesivirIBA 01/2021
1	Complement System Proteins (Complement)IBA 01/2021
1	Viral ProteinsIBA 01/2021
1	B-Lymphocyte Epitopes (B-Cell Epitope)IBA 08/2020
1	Peptide LibraryIBA 08/2020
1	Glycoproteins (Glycoprotein)IBA 01/2020
1	Explosive Agents (Explosives)IBA 01/2020
1	Immunodominant EpitopesIBA 01/2020
1	Interferon-gamma (Interferon, gamma)IBA 03/2018
1	Viral RNAIBA 01/2018
1	Steroid 12-alpha-Hydroxylase (CYP8B1)IBA 01/2018
1	LipidsIBA 01/2018
1	CholesterolIBA 01/2018
1	Interferon Regulatory Factor-1 (Interferon Regulatory Factor 1)IBA 01/2018
1	Interleukin-10 (Interleukin 10)IBA 01/2018
1	Chloroquine (Aralen)FDA LinkGeneric 01/2018
1	Bile Acids and Salts (Bile Acids)IBA 01/2018
1	C-Reactive ProteinIBA 01/2018
1	InflammasomesIBA 10/2017
1	N- (1,2,3,5,6,7- hexahydro- S- indacen- 4- ylcarbamoyl)- 4- (2- hydroxy- 2- propanyl)- 2- furansulfonamideIBA 10/2017
1	Nucleic AcidsIBA 07/2017
1	Chemokine CCL2 (Monocyte Chemoattractant Protein 1)IBA 04/2017
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 04/2017
1	prostratinIBA 03/2017
1	Phorbol EstersIBA 03/2017
1	T-Cell Antigen Receptors (T-Cell Receptor)IBA 01/2017
1	Matrix Metalloproteinase 2 (Gelatinase A)IBA 01/2017

Therapy/Procedure

6	Therapeutics 01/2021 - 12/2011
3	Artificial Respiration (Mechanical Ventilation) 11/2021 - 09/2020
1	Drug Therapy (Chemotherapy) 01/2021
1	Immunotherapy 03/2018